Search research articles
Contact Us
Filters
Showing results (51-60 of 341) with videos related to
Page
of 35
Sort By:
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
April 29, 2004
Jewish religious ethics mandate access to antiretroviral drugs in developing countries
Shalom C Spira, Mark A Wainberg
Expert Review of Anti-Infective Therapy
|
February 23, 2013
Harnessing the therapeutic potential of host antiviral restriction factors that target HIV
Richard D Sloan, Mark A Wainberg
Annals of Medicine
|
November 20, 2012
Update on rilpivirine: a new potent non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV replication
Gerasimos J Zaharatos, Mark A Wainberg
Cell Host & Microbe
|
April 20, 2011
XMRV as a human pathogen?
Mark A Wainberg, Kuan-Teh Jeang
Retrovirology
|
July 5, 2011
The role of unintegrated DNA in HIV infection
Richard D Sloan, Mark A Wainberg
Retrovirology
|
July 20, 2011
Jean-Luc Darlix: Renaissance scientist and retrovirologist par excellence
Mark A Wainberg, Eric A Cohen
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 15, 2013
Future of phylogeny in HIV prevention
Bluma G Brenner, Mark A Wainberg
Journal of Virus Eradication
|
August 3, 2016
HIV-1 resistance to dolutegravir: update and new insights
Mark A Wainberg, Ying-Shan Han
Retrovirology
|
July 5, 2007
Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome
James B Whitney, Mark A Wainberg
BMC Medicine
|
November 4, 2008
25 years of HIV-1 research - progress and perspectives
Mark A Wainberg, Kuan-Teh Jeang
Page
of 35
Search research articles
Search
Showing results (51-60 of 341) with videos related to
Sort By:
Page
of 35
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)
|
April 29, 2004
Jewish religious ethics mandate access to antiretroviral drugs in developing countries
Shalom C Spira, Mark A Wainberg
Expert Review of Anti-Infective Therapy
|
February 23, 2013
Harnessing the therapeutic potential of host antiviral restriction factors that target HIV
Richard D Sloan, Mark A Wainberg
Annals of Medicine
|
November 20, 2012
Update on rilpivirine: a new potent non-nucleoside reverse transcriptase inhibitor (NNRTI) of HIV replication
Gerasimos J Zaharatos, Mark A Wainberg
Cell Host & Microbe
|
April 20, 2011
XMRV as a human pathogen?
Mark A Wainberg, Kuan-Teh Jeang
Retrovirology
|
July 5, 2011
The role of unintegrated DNA in HIV infection
Richard D Sloan, Mark A Wainberg
Retrovirology
|
July 20, 2011
Jean-Luc Darlix: Renaissance scientist and retrovirologist par excellence
Mark A Wainberg, Eric A Cohen
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 15, 2013
Future of phylogeny in HIV prevention
Bluma G Brenner, Mark A Wainberg
Journal of Virus Eradication
|
August 3, 2016
HIV-1 resistance to dolutegravir: update and new insights
Mark A Wainberg, Ying-Shan Han
Retrovirology
|
July 5, 2007
Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome
James B Whitney, Mark A Wainberg
BMC Medicine
|
November 4, 2008
25 years of HIV-1 research - progress and perspectives
Mark A Wainberg, Kuan-Teh Jeang
Page
of 35